Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational StatusOlivier Mir, Charles Honoré, Ali N Chamseddine, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2025
Establishing Albumin-Bilirubin Score Changes as Predictors of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Post-External Beam Radiation TherapyKanokphorn Thonglert, Smith Apisarnthanarax, Beow Y Yeap, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 14, 2026
Brain volumes in fetuses with congenital heart disease and placental vascular abnormalitiesErin A O'Brien, David Wypij, Valerie Rofeberg, et al.
Nucleic Acids Research|July 18, 2023
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemiasMathias Boulanger, Mays Aqrouq, Denis Tempé, et al.
Oncotarget|December 6, 2022
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patientsYehia I Mohamed, Dan G Duda, Muhammad O Awiwi, et al.
Circulation. Arrhythmia and Electrophysiology|August 28, 2024
Outcomes of Atrial Fibrillation Ablation in Heart Failure SubtypesArwa Younis, Chadi Tabaja, Pasquale Santangeli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 12, 2026
Rapid Drug Desensitization in Pediatric Patients: A Multicenter StudySummer Tk Sze, Daniel Leung, Alan A Nguyen, et al.
Oncotarget|March 9, 2018
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsGuillermo Montalban-Bravo, Koichi Takahashi, Keyur Patel, et al.
Pageof 29